BioSpace News Archive

Thrive Global announced today a groundbreaking program in partnership with Stanford Medicine to help companies unlock better mental health

Lyra Therapeutics, Inc., a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat (ENT) diseases, today announced that Dana Washburn, M.D., has joined as the company’s Chief Medical Officer.

Despite being world leaders in cannabis, American cannabis businesses and investors’ profits are suffering due to the strict federal laws that specifically prohibit them exporting cannabis to Europe and Canada, both of which are prospering due to the changing laws and stances on medical cannabis.

Creative Medical Technology Holdings, Inc., a leading commercial stage biotechnology company focused on Urology, Neurology and Orthopedics using stem cell treatments, provided shareholder updates.

Seattle Genetics, Inc. (Nasdaq:SGEN) today announced dosing of the first patient in HER2CLIMB-02, a randomized phase 3 clinical trial evaluating investigational agent tucatinib versus placebo, in combination with standard-of-care ado-trastuzumab emtansine (T-DM1, Kadcyla®), for patients with locally advanced or metastatic HER2-positive (HER2+) breast cancer

Ocutrx Vision Technologies, LLC, a California-based technology startup developing a state-of-the-art augmented reality headset, is excited to reveal the company’s most significant technology milestone to date—a next generation AR headset technology for Surgery Visualization called the ORLenz™, a second medical device related to their flagship Oculenz™ ARWear™ headset for Macular Degeneration

According to the principles for the appointment of the Nomination Committee in Oncopeptides AB adopted at the annual general meeting held on May 21st, 2019, the Nomination Committee for the annual general meeting 2020 shall be composed of members appointed by the three largest shareholders in terms of voting rights as of September 30th,

Those who live long enough will experience at least one eye condition during their lifetime, which is why today, on World Sight Day, Calgary-based Operation Eyesight is encouraging us all to make eye health a global priority.

Myovant Sciences (NYSE: MYOV), a healthcare company focused on developing innovative treatments for women’s health and prostate cancer, today announced that results from its Phase 3 LIBERTY 1 & 2 studies of relugolix combination therapy in women with heavy menstrual bleeding associated with uterine fibroids will be presented in the late-breaking oral session at the 2019 American Society for Reproductive Medicine (ASRM) Scientific Congress,

Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, announced that Michael Feldschuh, Chief Executive Officer of Daxor, will be a featured presenter at the inaugural MicroCap Rodeo Investor Conference in Austin, Texas at the Hilton Austin on Tuesday, October 15th at 1:30 PM (CT).